- YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics. Proceedings of the National Academy of Sciences of the United States of America. 2018 Academic Article GET IT
Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma.
Disease models & mechanisms.
Times cited: 47
Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors.
Genes and Development.
Times cited: 303